IRCT2016092813739N5CompletedPhase 1
Comparing the effects of a-L-Guluronic acid with conventional Non-steroidal anti-inflammatory drugs on disease activity and inflammatory markers in patients with Rheumatoid Arthritis
Vice-Chancellor for Research, Tehran University of Medical Sciences0 sites36 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 36
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 25 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •Inclusion Criteria: 25-60 years old patients, Diagnosed with RA according to American College of Rheumatology Diagnostic Criteria after the initial visit by a specialist in rheumatology and parameters ESR, RF, CRP and Anti-CCP elected, Each patient must sign written informed consent.
Exclusion Criteria
- •History of fever and Infectious diseases, Positive pregnancy test or Lactation, Other collagen- vascular diseases, Other auto-immune diseases, Malignancies, Patients have enrolled another clinical trial study within last 4 weeks, Other concomitant diseases (Hepatic, renal, haematological, gastrointestinal, endocrine, cardiovascular, pulmonary, neurological or cerebral disease).
Investigators
Similar Trials
Completed
Phase 1
The therapeutic effects of a-L-Guluronic acid in patients with ankylosing spondylitisAnkylosing spondylitis.Ankylosing spondylitisIRCT2016091813739N4Vice-Chancellor for Research, Tehran University of Medical Sciences25
Completed
Phase 1
The therapeutic effect of Glucuronic acid in breast cancer patientsCondition 1: Breast Cancer. Condition 2: Breast Cancer. Condition 3: Breast Cancer. Condition 4: Breast Cancer. Condition 5: Breast Cancer. Condition 6: Breast Cancer. Condition 7: Breast Cancer. Condition 8: Breast Cancer.Malignant neoplasm: overlapping lesion of breastMalignant neoplasm: upper-inner quadrant of breastMalignant neoplasm: lower-inner quadrant of breastMalignant neoplasm: upper-outer quadrant of breastMalignant neoplasm: lower-outer quadrant of breastMalignant neoplasm: axillary tail of breastMalignant neoplasm: breast, unspecifiedMalignant neoplasm: nipple and areolaIRCT2017061113739N9Vice-Chancellor for Research, Tehran University of Medical Sciences36
Not yet recruiting
Phase 3
Evaluation of efficacy and safety of Glurunic acid (G2013) in patients with COVID-19COVID-19.Covid-19U07.1IRCT20080901001165N64Ministry of Defense, Department of Health180
Completed
Not Applicable
Effects of oral administration of lauric acid on gut hormone release and appetite perceptions in healthy peopleType 2 diabetesHealthy Human Gastrointestinal PhysiologyDiet and Nutrition - ObesityOral and Gastrointestinal - Normal oral and gastrointestinal development and functionMetabolic and Endocrine - DiabetesObesityACTRN12619000075189Prof. Christine Feinle-Bisset10
Completed
Not Applicable
Treatment of Acne scarsCTRI/2018/02/012050Andrea Rosario30